Francesca Chamian

2.9k total citations · 2 hit papers
14 papers, 2.4k citations indexed

About

Francesca Chamian is a scholar working on Immunology, Dermatology and Physiology. According to data from OpenAlex, Francesca Chamian has authored 14 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Dermatology and 3 papers in Physiology. Recurrent topics in Francesca Chamian's work include Psoriasis: Treatment and Pathogenesis (10 papers), T-cell and B-cell Immunology (8 papers) and Dermatology and Skin Diseases (6 papers). Francesca Chamian is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), T-cell and B-cell Immunology (8 papers) and Dermatology and Skin Diseases (6 papers). Francesca Chamian collaborates with scholars based in United States and Canada. Francesca Chamian's co-authors include James G. Krueger, Edmund Lee, Frank Wang, Michelle A. Lowes, William L. Trepicchio, Madhav V. Dhodapkar, Judith Oestreicher, Debra D. Pittman, Irma Cardinale and Knut M. Wittkowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The Journal of Experimental Medicine.

In The Last Decade

Francesca Chamian

14 papers receiving 2.3k citations

Hit Papers

Increased Expression of Interleukin 23 p19 and p40 in Les... 2004 2026 2011 2018 2004 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Chamian United States 14 2.0k 889 460 437 245 14 2.4k
Artemis Khatcherian United States 12 1.7k 0.9× 1.2k 1.4× 507 1.1× 322 0.7× 234 1.0× 13 2.3k
James T. Elder United States 23 1.7k 0.9× 982 1.1× 409 0.9× 351 0.8× 716 2.9× 34 2.6k
Jean S. Beebe United States 19 415 0.2× 254 0.3× 108 0.2× 314 0.7× 636 2.6× 39 1.7k
Nandini Kishore United States 15 690 0.3× 124 0.1× 100 0.2× 601 1.4× 451 1.8× 20 1.9k
Colin Veal United Kingdom 17 477 0.2× 218 0.2× 185 0.4× 127 0.3× 182 0.7× 25 941
Michael I. Jesson United States 13 467 0.2× 140 0.2× 62 0.1× 666 1.5× 274 1.1× 21 1.6k
Joseph C. Marini United States 17 748 0.4× 60 0.1× 140 0.3× 177 0.4× 376 1.5× 29 1.5k
Robert Loewe Austria 21 512 0.3× 196 0.2× 116 0.3× 647 1.5× 569 2.3× 46 1.5k
Debra M. Meyer United States 11 411 0.2× 105 0.1× 70 0.2× 393 0.9× 195 0.8× 13 1.2k
Garvin L. Warner United States 21 807 0.4× 70 0.1× 89 0.2× 217 0.5× 349 1.4× 36 1.4k

Countries citing papers authored by Francesca Chamian

Since Specialization
Citations

This map shows the geographic impact of Francesca Chamian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Chamian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Chamian more than expected).

Fields of papers citing papers by Francesca Chamian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Chamian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Chamian. The network helps show where Francesca Chamian may publish in the future.

Co-authorship network of co-authors of Francesca Chamian

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Chamian. A scholar is included among the top collaborators of Francesca Chamian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Chamian. Francesca Chamian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Guttman‐Yassky, Emma, Yulia Vugmeyster, Michelle A. Lowes, et al.. (2008). Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness. Journal of Investigative Dermatology. 128(5). 1182–1191. 48 indexed citations
2.
Chamian, Francesca, Edmund Lee, Toyoko Kikuchi, et al.. (2007). Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis. Journal of Translational Medicine. 5(1). 27–27. 59 indexed citations
3.
Lowes, Michelle A., Francesca Chamian, Craig L. Leonardi, et al.. (2007). Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series. BMC Dermatology. 7(1). 2–2. 16 indexed citations
4.
Haider, Asifa, Michelle A. Lowes, Humphrey Gardner, et al.. (2007). Novel Insight into the Agonistic Mechanism of Alefacept In Vivo: Differentially Expressed Genes May Serve as Biomarkers of Response in Psoriasis Patients. The Journal of Immunology. 178(11). 7442–7449. 43 indexed citations
5.
Wang, Frank, Edmund Lee, Michelle A. Lowes, et al.. (2006). Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects. Journal of Investigative Dermatology. 126(7). 1590–1599. 86 indexed citations
6.
Gottlieb, Alice B., Francesca Chamian, Irma Cardinale, et al.. (2005). TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques. The Journal of Immunology. 175(4). 2721–2729. 305 indexed citations
7.
Chamian, Francesca, Michelle A. Lowes, Shao‐Lee Lin, et al.. (2005). Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proceedings of the National Academy of Sciences. 102(6). 2075–2080. 178 indexed citations
8.
Lowes, Michelle A., Francesca Chamian, Judilyn Fuentes‐Duculan, et al.. (2005). Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proceedings of the National Academy of Sciences. 102(52). 19057–19062. 373 indexed citations breakdown →
9.
Lee, Edmund, William L. Trepicchio, Judith Oestreicher, et al.. (2004). Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris. The Journal of Experimental Medicine. 199(1). 125–130. 738 indexed citations breakdown →
10.
Dhodapkar, Kavita M., Francesca Chamian, David Zagzag, et al.. (2004). Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell‐mediated expansion. International Journal of Cancer. 109(6). 893–899. 95 indexed citations
11.
Wittkowski, Knut M., Edmund Lee, Rachel Nussbaum, Francesca Chamian, & James G. Krueger. (2004). Combining several ordinal measures in clinical studies. Statistics in Medicine. 23(10). 1579–1592. 70 indexed citations
12.
Vugmeyster, Yulia, Toyoko Kikuchi, Michelle A. Lowes, et al.. (2004). Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. Clinical Immunology. 113(1). 38–46. 57 indexed citations
13.
Chamian, Francesca & James G. Krueger. (2004). Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis. Current Opinion in Rheumatology. 16(4). 331–337. 64 indexed citations
14.
Helms, Cynthia, Li Cao, James G. Krueger, et al.. (2003). A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nature Genetics. 35(4). 349–356. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026